111 related articles for article (PubMed ID: 17196347)
1. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
[TBL] [Abstract][Full Text] [Related]
2. A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches.
Al-Taie A; Özcan Bülbül E
J Drug Target; 2024 Dec; 32(1):45-56. PubMed ID: 38096045
[TBL] [Abstract][Full Text] [Related]
3. Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.
Mu Q; Kievit FM; Kant RJ; Lin G; Jeon M; Zhang M
Nanoscale; 2015 Nov; 7(43):18010-4. PubMed ID: 26469772
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization.
Mathieu C; Ghosh S; Draussin J; Gasser A; Jacquot G; Banerjee M; Gupta T; Schmutz M; Mirjolet C; Tillement O; Lux F; Klymchenko AS; Donzeau M; Pivot X; Harlepp S; Detappe A
Adv Healthc Mater; 2024 Jun; 13(15):e2304250. PubMed ID: 38444191
[TBL] [Abstract][Full Text] [Related]
5. B cell-targeted polylactic acid nanoparticles as platform for encapsulating jakinibs: potential therapeutic strategy for systemic lupus erythematosus.
Álvarez K; Palacio J; Agudelo NA; Anacona CA; Castaño D; Vásquez G; Rojas M
Nanomedicine (Lond); 2023 Nov; 18(27):2001-2019. PubMed ID: 38084660
[TBL] [Abstract][Full Text] [Related]
6. Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles.
Park J; Chariou PL; Steinmetz NF
Bioconjug Chem; 2020 May; 31(5):1408-1416. PubMed ID: 32281790
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.
Galvin P; Thompson D; Ryan KB; McCarthy A; Moore AC; Burke CS; Dyson M; Maccraith BD; Gun'ko YK; Byrne MT; Volkov Y; Keely C; Keehan E; Howe M; Duffy C; MacLoughlin R
Cell Mol Life Sci; 2012 Feb; 69(3):389-404. PubMed ID: 22015612
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy.
Gawęda W; Pruszyński M; Cędrowska E; Rodak M; Majkowska-Pilip A; Gaweł D; Bruchertseifer F; Morgenstern A; Bilewicz A
Nanomaterials (Basel); 2020 Oct; 10(10):. PubMed ID: 33092037
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging-guided cancer therapy with fluorescent nanoparticles.
Jiang S; Gnanasammandhan MK; Zhang Y
J R Soc Interface; 2010 Jan; 7(42):3-18. PubMed ID: 19759055
[TBL] [Abstract][Full Text] [Related]
10. Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy.
Fatima I; Rahdar A; Sargazi S; Barani M; Hassanisaadi M; Thakur VK
J Funct Biomater; 2021 Dec; 12(4):. PubMed ID: 34940554
[TBL] [Abstract][Full Text] [Related]
11. Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia.
Gawęda W; Osial M; Żuk M; Pękała M; Bilewicz A; Krysinski P
Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32046284
[TBL] [Abstract][Full Text] [Related]
12.
Monoclon Antib Immunodiagn Immunother; 2024 Apr; ():. PubMed ID: 38625004
[No Abstract] [Full Text] [Related]
13. Secondary syphilis occurring under anti-CD20 therapy: risks, progression and approach.
Garbers LAFM; Haes TM; Silva Souza CD
An Bras Dermatol; 2024; 99(4):632-634. PubMed ID: 38614937
[No Abstract] [Full Text] [Related]
14. Effect of the Protein Corona Formation on Antibody Functionalized Liquid Lipid Nanocarriers.
Navarro-Marchal SA; Martín-Contreras M; Castro-Santiago D; Del Castillo-Santaella T; Graván P; Jódar-Reyes AB; Marchal JA; Peula-García JM
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069079
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled Human Serum Albumin Nanoparticles Co-Loaded with Methotrexate and Decorated with Trastuzumab for Breast Cancer Diagnosis.
Ekinci M; Alencar LMR; Lopes AM; Santos-Oliveira R; İlem-Özdemir D
J Funct Biomater; 2023 Sep; 14(9):. PubMed ID: 37754891
[TBL] [Abstract][Full Text] [Related]
16. Cell surface GRP78: a potential mechanism of therapeutic resistant tumors.
Amaresan R; Gopal U
Cancer Cell Int; 2023 May; 23(1):100. PubMed ID: 37221596
[TBL] [Abstract][Full Text] [Related]
17. PLGA Particles in Immunotherapy.
Horvath D; Basler M
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839937
[TBL] [Abstract][Full Text] [Related]
18. Dendrimer-Based Nanomedicine (Paramagnetic Nanoparticle, Nanocombretastatin, Nanocurcumin) for Glioblastoma Multiforme Imaging and Therapy.
Brown SL; Snyder JM; Ali MM
Nov Approaches Cancer Study; 2021; 6(3):609-614. PubMed ID: 35237758
[TBL] [Abstract][Full Text] [Related]
19. CD123-Targeted Nano-Curcumin Molecule Enhances Cytotoxic Efficacy in Leukemic Stem Cells.
Nirachonkul W; Ogonoki S; Thumvijit T; Chiampanichayakul S; Panyajai P; Anuchapreeda S; Tima S; Chiampanichayakul S
Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835741
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression.
Song L; Zhang W; Chen H; Zhang X; Wu H; Ma M; Wang Z; Gu N; Zhang Y
Int J Nanomedicine; 2019; 14():921-936. PubMed ID: 30787607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
